Under the direction of Drs. Fred Gordin (DC VAMC), Lawrence D'Angelo (CNMC), and Mary Young (GU), the primary goal ofthe DC D-CFAR CLINICAL CORE C is to expand and strengthen existing collaborations between 5 academic medical centers and 2 major community providers of HIV/AIDS care in DC in order to encourage and support new investigators ~ women, minorities, and early- and mid-career scientists ~ to embark on innovative, multidisciplinary, and multiinstitutional clinical and translational research initiatives and to provide them the tools and support needed at multiple levels to be successful in competing for their own federal research awards. The ultimate aim ofthe DC D-CFAR is to address the urgent public health and research needs of impoverished populations in this high prevalence area and to seek new ways to intervene and bridge research gaps from bench to bedside to the community. Clinical Core C brings generous institutional support for the efforts of experienced research investigators to make an impact on the DC epidemic. Core C activities will also be supported through direct CFAR support, charge-backs to Core C users as appropriate, and other options. Core C enhances and adds value to the clinical and translational research activities of DC D-CFAR investigators through the following four Specific Aims: 1. To promote multidisciplinary clinical and translational HIV/AIDS research at seven collaborating clinical sites; 2. To mentor and train new investigators, especially women and minorities, in the design and implementation of innovative multidisciplinary clinical and translational HIV/AIDS research projects supported through the DC D-CFAR Developmental Core B; 3. To promote use by investigators of the DC D-CFAR Repository and Database and other local repository and database resources; 4. To provide outreach and education to DC D-CFAR key stakeholders - the HIV/AIDS community, patients, investigators, and staff at collaborating sites- about DC D-CFAR clinical research opportunities, developments, and outcomes.

Public Health Relevance

Participating sites: (1) Children's National Medical Center (CNMC);(2) George Washington University Medical Center (GW);(3) Georgetown University Hospital (GU);(4) Howard University Hospital (HU);(5) DC Veterans Affairs Medical Center (DC VAMC);(6) Unity Health Care, Inc. (UNITY);(7) Whitman-Walker Clinic (WWC), all in the District of Columbia, where adult prevalence of HIV infection is estimated at 3%, and even higher in certain sub-groups.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI087714-05
Application #
8668891
Study Section
Special Emphasis Panel (ZAI1-JBS-A)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
5
Fiscal Year
2014
Total Cost
$98,905
Indirect Cost
$32,502
Name
George Washington University
Department
Type
DUNS #
043990498
City
Washington
State
DC
Country
United States
Zip Code
20052
Xia, Jie; Reid, Terry-Elinor; Wu, Song et al. (2018) Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis. J Chem Inf Model 58:1104-1120
Xia, Jie; Hu, Huabin; Xue, Wenjie et al. (2018) The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay. J Enzyme Inhib Med Chem 33:525-535
Pérez-Losada, Marcos; Arenas, Miguel; Castro-Nallar, Eduardo (2018) Microbial sequence typing in the genomic era. Infect Genet Evol 63:346-359
Leal, Fabio E; Menezes, Soraya Maria; Costa, Emanuela A S et al. (2018) Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-? Response in HTLV-1-Associated Neuroinflammation. Front Microbiol 9:985
Jones, R Brad; Mueller, Stephanie; Kumari, Sudha et al. (2017) Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells. Biomaterials 117:44-53
Raposo, Rui André Saraiva; de Mulder Rougvie, Miguel; Paquin-Proulx, Dominic et al. (2017) IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight 2:e85811
Stock, Michelle L; Peterson, Laurel M; Molloy, Brianne K et al. (2017) Past racial discrimination exacerbates the effects of racial exclusion on negative affect, perceived control, and alcohol-risk cognitions among Black young adults. J Behav Med 40:377-391
de Mulder, Miguel; SenGupta, Devi; Deeks, Steven G et al. (2017) Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. Retrovirology 14:41
Farmer, Shu; Mindry, Deborah; Comulada, W Scott et al. (2017) Mobile Phone Ecological Momentary Assessment of Daily Stressors Among People Living With HIV: Elucidating Factors Underlying Health-Related Challenges in Daily Routines. J Assoc Nurses AIDS Care 28:737-751
Calabrese, Sarah K; Magnus, Manya; Mayer, Kenneth H et al. (2017) ""Support Your Client at the Space That They're in"": HIV Pre-Exposure Prophylaxis (PrEP) Prescribers' Perspectives on PrEP-Related Risk Compensation. AIDS Patient Care STDS 31:196-204

Showing the most recent 10 out of 174 publications